Nivolumab Injections Could Make Treatment Easier for More People with Cancer - Cancer Currents Blog

Having trouble viewing this email? View it as a Web page.
Latest from Cancer Currents
03/13/2024
In a clinical trial, an injectable form of nivolumab (Opdivo) was as effective against kidney cancer as the intravenous form of the drug. Side effects were also similar and treatment time was shorter. Injectable immunotherapies, several experts said, if found to be comparable to IV forms, can be more convenient to receive and accessible to more people.

Read the Story

You are subscribed to the latest posts from Cancer Currents: An NCI Cancer Research Blog from the National Cancer Institute. Update your subscriptions.

Bookmark and Share